CAS: 1650550-25-6 - Enasidenib (mesylate)
- Synonyms:
- 2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol methanesulfonate
- AG-221 mesylate
- AG-221 salt
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Enasidenibmesylate REF: IN-DA01E6UNCAS: 1650550-25-6 | 98% | To inquire | Tue 07 Jan 25 |
 | Enasidenib mesylate REF: TM-T2346LCAS: 1650550-25-6 | 99.86% | 47.00 €~344.00 € | Tue 07 Jan 25 |
 | Enasidenib Mesylate REF: 4Z-K-031042CAS: | - - - | To inquire | Mon 13 Jan 25 |
 | Enasidenib mesylate REF: 3D-FE165474CAS: 1650550-25-6 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01E6UN
| 50mg | 513.00 € | ||
| 100mg | 616.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Enasidenib mesylate
CAS:1650550-25-6
Enasidenib mesylate (AG-221 mesylate) is a IDH2 inhibitor that promotes differentiation of leukemia myeloid cells …
Formula:
C20H21F6N7O4S
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
569.48
Ref: TM-T2346L
| 5mg | 47.00 € | ||
| 10mg | 69.00 € | ||
| 25mg | 96.00 € | ||
| 50mg | 110.00 € | ||
| 100mg | 143.00 € | ||
| 500mg | 344.00 € | ||
| 1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-K-031042
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Enasidenib mesylate
CAS:1650550-25-6
Inhibitor of isocitrate dehydrogenase IDH2
Formula:
C19H17F6N7O•CH4O3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
569.48 g/mol
Ref: 3D-FE165474
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
